3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Non-Hodgkin
3
Lymphoma, T-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lung Neoplasms
2
Glioma
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Osteosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Medulloblastoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hodgkin Disease
1
Histiocytosis, Langerhans-Cell
1
Hepatoblastoma
1
Ependymoma
1
Endometrial Neoplasms
1
Endometrial Hyperplasia
1
Diffuse Intrinsic Pontine Glioma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Paclitaxel
40
Carboplatin
34
Bevacizumab
29
liposomal doxorubicin
20
Specimen Handling
18
Taxes
17
olaparib
16
Magnetic Resonance Spectroscopy
16
pembrolizumab
15
Gemcitabine
15
Topotecan
13
Immunoglobulin G
11
Disulfides
11
Biopsy
11
mirvetuximab soravtansine
8
niraparib
7
Nivolumab
7
Doxorubicin
7
Cyclophosphamide
6
Cisplatin
6
Drug Therapy
5
130-nm albumin-bound paclitaxel
5
cemiplimab
4
cediranib
4
Letrozole
4
Injections
4
Docetaxel
4
1-dodecylpyridoxal
4
sarilumab
3
rucaparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
Pharmacogenomic Variants
×
1 year
×
Clear all
No trials found.